Close
Nordic 9Nordic 9

Ro Invest (investor - Venture Capital)

Norway
See something wrong or missing? Let us know
Offices:Oslo
Average round investment:626k USD
Average number per year:1.5
Distribution: 2020 (1)2011 (2)
Portfolio companies: Norway Zelluna Immunotherapy AsNorway APIM Therapeutics
Mostly invests in: Norway Norway (3) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Ro Invest mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ro Invest

Name Criteria
Norway Birk Venture
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Dreamers Startup Ventures
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States M12
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mayfield Fund
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Sauli Törmälä
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden STING
65%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Sweden PÄAB
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Denmark Accelerace
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom Angel Investment Network
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain Chamberí Ventures
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top